JPH0242805B2 - - Google Patents
Info
- Publication number
- JPH0242805B2 JPH0242805B2 JP5399982A JP5399982A JPH0242805B2 JP H0242805 B2 JPH0242805 B2 JP H0242805B2 JP 5399982 A JP5399982 A JP 5399982A JP 5399982 A JP5399982 A JP 5399982A JP H0242805 B2 JPH0242805 B2 JP H0242805B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- production example
- theoretical value
- product
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 27
- 235000001014 amino acid Nutrition 0.000 claims description 24
- 150000001413 amino acids Chemical class 0.000 claims description 23
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 6
- 150000001371 alpha-amino acids Chemical class 0.000 claims description 4
- 230000007065 protein hydrolysis Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 description 49
- 239000000047 product Substances 0.000 description 38
- 229940024606 amino acid Drugs 0.000 description 24
- 239000002253 acid Substances 0.000 description 23
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 19
- 238000000034 method Methods 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- -1 acylate amino acids Chemical class 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 230000036571 hydration Effects 0.000 description 8
- 238000006703 hydration reaction Methods 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000010933 acylation Effects 0.000 description 5
- 238000005917 acylation reaction Methods 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- WPSSBBPLVMTKRN-UHFFFAOYSA-N butyrylglycine Chemical compound CCCC(=O)NCC(O)=O WPSSBBPLVMTKRN-UHFFFAOYSA-N 0.000 description 4
- 229960003067 cystine Drugs 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- CKZKECCDSFADJU-CJORJKIQSA-N (2r)-2-amino-3-[[(2r)-2-amino-2-carboxyethyl]disulfanyl]-4-oxoheptanoic acid Chemical compound CCCC(=O)C([C@H](N)C(O)=O)SSC[C@H](N)C(O)=O CKZKECCDSFADJU-CJORJKIQSA-N 0.000 description 3
- NZIOTNYOYJRBSN-ZETCQYMHSA-N (2s)-2-(butanoylamino)-4-methylsulfanylbutanoic acid Chemical compound CCCC(=O)N[C@H](C(O)=O)CCSC NZIOTNYOYJRBSN-ZETCQYMHSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- PNRXXKVCHJXHPZ-ZETCQYMHSA-N (2s)-1-butanoylpyrrolidine-2-carboxylic acid Chemical compound CCCC(=O)N1CCC[C@H]1C(O)=O PNRXXKVCHJXHPZ-ZETCQYMHSA-N 0.000 description 2
- XFBGKIUQJKBFIO-QMMMGPOBSA-N (2s)-2-(butanoylamino)-3-methylbutanoic acid Chemical compound CCCC(=O)N[C@@H](C(C)C)C(O)=O XFBGKIUQJKBFIO-QMMMGPOBSA-N 0.000 description 2
- POHGHGLKBPAVNJ-RQJHMYQMSA-N (2s,4r)-1-butanoyl-4-hydroxypyrrolidine-2-carboxylic acid Chemical compound CCCC(=O)N1C[C@H](O)C[C@H]1C(O)=O POHGHGLKBPAVNJ-RQJHMYQMSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000006229 carbon black Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940100242 glycol stearate Drugs 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000037067 skin hydration Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- JLGDXLJLBLWEPD-YFKPBYRVSA-N (2r)-2-(butanoylamino)-3-sulfanylpropanoic acid Chemical compound CCCC(=O)N[C@@H](CS)C(O)=O JLGDXLJLBLWEPD-YFKPBYRVSA-N 0.000 description 1
- POWFRKKVHBUFNI-NSHDSACASA-N (2s)-2-(butanoylamino)-3-phenylpropanoic acid Chemical compound CCCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 POWFRKKVHBUFNI-NSHDSACASA-N 0.000 description 1
- AMFCTBFEZLOQFN-VDTYLAMSSA-N (2s,3r)-2-(butanoylamino)-3-hydroxybutanoic acid Chemical compound CCCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AMFCTBFEZLOQFN-VDTYLAMSSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- CHRXIJXXDQWKCQ-UHFFFAOYSA-N 2-[(4-hydroxy-4-methyloxan-3-yl)azaniumyl]acetate Chemical compound CC1(O)CCOCC1NCC(O)=O CHRXIJXXDQWKCQ-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OJZJSCKVLIQHTK-JEDNCBNOSA-N C(C)O.C(CCC)(=O)N[C@@H](CS)C(=O)O Chemical compound C(C)O.C(CCC)(=O)N[C@@H](CS)C(=O)O OJZJSCKVLIQHTK-JEDNCBNOSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000006181 N-acylation Effects 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- JSOMVCDXPUXKIC-UHFFFAOYSA-N tert-butyl 3-oxopyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)C1 JSOMVCDXPUXKIC-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
本発明はα−アミノ酸またはその混合物のN−
アシル化物の少なくとも1種を活性成分とする新
規な化粧料組成物に関する。アミノ酸またはその
混合物を、分子鎖中に5個より多くの炭素原子を
含有する脂肪酸によりアシル化することは公知で
ある。しかしながら、これらの公知のアシル化物
は脂溶性であるが、一般的に、水および通常の溶
剤には不溶性である。
今般、本発明者はα−アミノ酸またはその混合
物を酪酸でアシル化することにより、脂溶性であ
つてかつ水および多くの極性および非極性溶剤に
も可溶性であるアシル化物が得られることを知見
した。特に、アミノ酸またはその混合物を酪酸で
アシル化することにより、アルコール、ケトン
類、酢酸エチル、ベンゼン、クロロホルム、ジエ
チルエーテル等に可溶性の生成物が得られる。勿
論、脂肪、水および種々の溶剤に対する溶解度は
アミノ酸の種類により変動する。これらのアシル
化物はメタノールおよびクロロホルムのごとき極
性および非極性溶剤の混合物にも可溶性である
が、石油エーテル、ヘキサンには不溶性であり、
また、上記アシル化物のあるものはイソプロピル
エーテルに不溶性である。
アミノ酸またはその混合物を分子中に5個より
多くの炭素原子を含有する脂肪酸によりアシル化
して得られるリポアミノ酸と比較して、酪酸でア
シル化することにより、アシル基部の分子鎖がよ
り短いために、より大きな酸性化能力(これは遊
離したカルボキシル基の酸性度である)を有する
化合物が得られる。
このN−アシル化物は例えば皮膚からの良好な
滲透性を示し、また、化粧料の活性成分として有
用な効果を示す。
従つて本発明によれば、α−アミノ酸を酪酸に
よりアシル化して得られるα−アミノ酸のN−ア
シル化物の少なくとも1種を活性成分として含有
することを特徴とする、皮膚、毛髪及び爪保護用
化粧料組成物が提供される。
本発明においては、上記アシル化物と無機、有
機又は生物学的塩基又は金属との塩も同様に使用
し得る。
本発明によれば、α−アミノ酸を、任意の適当
な方法で得られたアミノ酸の混合物、例えば蛋白
質の完全加水分解により得られたアミノ酸の混合
物で置き換えることができる。
アミノ酸またはアミノ酸の混合物を酪酸でアシ
ル化して得られる生成物はいずれもN−アシル化
誘導体である;しかしながら、他の塩基性官能基
を有するアミノ酸においては、これらの官能基も
酪酸により部分的にあるいは完全にアシル化され
得る。
これらのアミノ酸またはその混合物のN−アシ
ル化物の塩に関して、この塩は任意の、適当な無
機または有機塩基例えば、トリエタノールアミ
ン、ジエチルアミンおよびモルホリンあるいはリ
シン、アルギニンまたはニチン(nithine)のご
とき種々の公知の塩基性アミノ酸、またはコリ
ン、グアニジンのごとき生物学的塩基の作用によ
り得られる。対応する塩は、単に、予め得られた
N−アシル化物と選択された塩基とを反応させる
ことにより得られる。
本発明のN−アシル化物の金属塩の製造に関し
て、かかる金属塩はN−アシル化物と選択された
金属の水酸化物または炭酸塩とを加温下で反応さ
せることにより容易に製造し得る;好ましい金属
はオリゴ元素(oligo−elements)として知られ
る金属である。
本発明で使用されるα−アミノ酸の酪酸による
N−アシル化物を製造する場合、遊離の酪酸を発
生してアミノ酸と完全に反応する無水酪酸を使用
することが好ましい;化学量論的量より10〜25%
過剰に使用することが好ましいが、処理されるア
ミノ酸が、アシル化される可能性のある他の官能
性基を有する場合には、使用すべき無水酪酸の適
当な割合を決定する際に、これらの官能性基の全
てを考慮に入れることが必要であろう。
以下に本発明で使用するα−アミノ酸の酪酸に
よるN−アシル化物の製造例を示す。
製造例1 ブチリルグリシンの製造
撹拌機を取付けたかつ水浴により加温された
500ml反応容器に30g(0.4モル)のグリシンを注
入しついで撹拌しながら30%の水酸化ナトリウム
溶液40mlをゆつくり添加した。
反応混合物が透明になつた時点で、65gの無水
酪酸をゆつくり添加しかつその際、添加が終了す
るまでPHを10〜10.5に保持した(温度40〜45℃)。
反応混合物を0.5時間、70℃で加温した後、冷却
した。
ブチリルグリシンをそのナトリウム塩から得る
ために、撹拌しながらPHが2になるまで塩酸をゆ
つくり添加した。かくして生じた油状上澄層を分
離し、減圧下で蒸留して(油浴上)、水と塩酸を
除去した。冷却後、石油エーテルを添加してブチ
リルグリシンを沈澱させかつ酪酸を除去した;こ
の処理は2回繰返した。
かくして51g(収率88%)の生成物が得られ、
その分析値は理論値(分子量145;C6H11NO3)
と完全に一致した:酸指数(acidindex);実測
値、382(理論値:386)。
製造例2 ブチリルフエニルアラニンの製造
33g(0.2モル)のフエニルアラニンと36gの
無水酪酸を使用して、製造例1と同一の方法を行
つた。
42g(収率90%)の生成物が得られ、その分析
値は理論値(分子量235;C13H17NO3)と完全に
一致した:酸指数;実測値、235(理論値:238)。
製造例3 ブチリルスレオニンの製造
36g(0.3モル)のスレオニンと51gの無水酪
酸を使用して、製造例1と同様の方法を行つた。
57g(収率99%)の生成物が得られ、その分析
値は理論値(分子量189;C8H15NO4)と完全に
一致した:酸指数;実測値、293(理論値:296)。
製造例4 ブチリルアスパラギン酸の製造
53g(0.4モル)のアスパラギン酸と64gの無
水酪酸を使用して、製造例1と同様の方法を行つ
た;ただし、水と塩酸の除去工程の後に、残留酪
酸を減圧下、130−140℃(油浴上)での蒸留によ
り除去することが必要であつた。無水残渣を等重
量の蒸留水ついでカーボンブラツクで処理した。
75g(収率94%)の生成物が得られ、その分析値
は理論値(分子量203;C8H13NO5)と完全に一
致した:酸指数;実測値、382(理論値386)。
製造例5 ブチリルバリンの製造
58g(0.5モル)のバリンと85gの無水酪酸と
を使用して、製造例1と同様の方法を行つた。ブ
チリルバリンは冷水に僅かしか溶解しないので、
酪酸の除去は氷水での洗浄により行つた。
85g(収率92%)の生成物が得られ、その分析
値は理論値(分子量187;C9H17NO3)と完全に
一致した:酸指数;実測値、294(理論値297)。
製造例6 ブチリルロイシンの製造
65g(0.5モル)のロイシンと85gの無水酪酸
を使用して、製造例1と同様の方法を行つた;ブ
チリルロイシンは冷水に僅かしか溶解しないの
で、酪酸の除去は製造例5と同様の方法で行つ
た。
89g(収率92%)の生成物が得られ、その分析
値は理論値(分子量201;C10H19NO3)と完全に
一致した:酸指数;実測値、277(理論値280)。
製造例7 ジブチリルリシンの製造
リシン(0.2モル)の50%溶液60gと、ジブチ
リル誘導体について64gの無水酪酸を使用して、
製造例1と同様の方法を行つた。
51g(収率85%)の生成物が得られ、その分析
値は理論値(分子量286;C14H26N2O2)と完全に
一致した:酸指数;実測値、193(理論値:195)。
製造例8 ブチリルプロリンの製造
23g(0.2モル)のプロリンと40gの無水酪酸
を使用して、製造例1と同様の方法を行つた。
34g(収率92%)の生成物が得られ、その分析
値は理論値(分子量185;C9H15NO3)と完全に
一致した:酸指数;実測値、304(理論値:302)。
製造例9 モノ−およびジブチリルヒドロキシプ
ロリンの製造
52g(0.4モル)のヒドロキシプロリンと75g
の無水酪酸とを使用して製造例1と同様の方法を
行つた。
75g(収率87%)の生成物が得られ、その分析
結果からこの生成物はモノ置換型(35%)とジ置
換型(65%)の混合物であることが判つた。これ
らの化合物についての理論値はつぎの通りであ
る:
モノ置換型:分子量201;C9H15NO4;酸指数
279、ジ置換型;分子量271;C13H21NO4;酸
指数207、酸指数についての実測値は230であつ
た。
製造例10 ジブチリルヒドロキシリシンの製造
32g(0.2モル)のヒドロキシリシンと40gの
無水酪酸とを使用して製造例1と同様の方法を行
つた。
53g(収率88%)の生成物が得られ、その分析
値は理論値(分子量302;C14H26N2O5)と完全に
一致した:酸指数;実測値、187(理論値:184)。
製造例11 ブチリルメチオニンの製造
45g(0.3モル)のメチオニンと50gの無水酪
酸とを使用して製造例1と同様の方法を行つた。
61g(収率92%)の生成物が得られ、その分析
値は理論値(分子量219;C9H17NO3S)と完全に
一致した:酸指数;実測値、257(理論値:255)。
製造例12 ジブチリルシスチンの製造
48g(0.2モル)のシスチンと64gの無水酪酸
を使用して製造例1と同一の方法を行つた。
73g(収率91%)の生成物が得られ、その分析
値は理論値(分子量380;C14H24N2O6S2)と完全
に一致した:酸指数;実測値、305(理論値:
294)。
製造例13 ブチリルシステインの製造
48g(0.4モル)のシステインと64gの無水酪
酸とを使用して製造例1と同一の方法を行つた。
71g(収率97%)の生成物が得られ、その分析
値は理論値(分子量191;C7H13NO3S)と完全に
一致した:酸指数;実測値、307(理論値:297)。
SH;実測値、16.8(理論値:17.1)。
以下に示す製造例は天然蛋白質の完全加水分解
により得られた、分離していないアミノ酸混合物
の酪酸によるアシル化物の製造に関するものであ
る。これらのアミノ酸混合物は実質的に、原料蛋
白質中に存在するアミノ酸を定量的かつ定性的な
割合で保有しているので、上記アミノ酸混合物は
原料蛋白質と同様の名称で表わした。
第1工程は選択された蛋白質から蛋白質加水分
解物を調製することからなる。200gの蛋白質を
慣用の方法に従つて濃塩酸で処理しついでペプチ
ドが存在しないことをビウレツト試験により確認
した後、溶液を中和し(PH6.5−7)、カーボンブ
ラツクで処理しついで濾過した。かく得られた溶
液をホルムアルデヒドにより滴定してアシル化に
利用し得るアミン官能基と使用すべき無水酪酸の
量とを測定した。加水分解物の試料を用いて乾燥
抽出物を調製し、秤量し、メタノールで処理して
塩化ナトリウムを除去しついで再びホルムアルデ
ヒドにより滴定した。
この予備操作により適当な割合の反応剤による
アシル化が可能になる。
製造例14 ブチリルコラーゲン酸の製造
原料蛋白質としてゼラチンを使用した。加水分
解物のアミノ酸の平均分子量は110であつた。約
50gのアミノ酸を含有する加水分解物200mlを製
造例1に述べた方法に従つて80gの無水酪酸によ
り処理した。アシル化物の分離は製造例4の同様
に蒸留により行い、74g(収率92%)を得た。そ
の分析値は理論値とよく一致した。
窒素含有量:実測値、8.2%(理論値:8%)
酸指数:実測値、335(理論値:327)
製造例15 ブチリルケラチン酸の製造
原料蛋白質として角(horn)を使用した。加
水分解物のアミノ酸の平均分子量は120であつた。
アシル化し得るアミノ官能性基の量はシスチンに
ついて測定した。アシル化物の製造は製造例14と
同様の方法に従つて300mlの加水分解物と80gの
無水酪酸とを使用して行つた;バリン、ロイシン
およびイソロイシンのアシル化物の溶解性を良好
にするために3〜5%のプロピレングリコールを
添加した。
87g(収率96%)の生成物が得られ、その分析
値は理論値と許容し得る範囲で一致した。
窒素含有量:実測値、8.2%(理論値:7.4
%);この相違はアミノ酸混合物中に二塩基性化
合物が存在することに基づくものである。
酸指数:実測値、287;ブチリルシスチンにつ
いての理論値は294である。
製造例16 ブチリルカゼイン酸の製造
原料蛋白質としてカゼインを使用した。加水分
解物のアミノ酸の平均分子量は120であつた。ア
シル化物の製造は製造例14と同様の方法に従つて
約41gのアミノ酸を含有する加水分解物300mlと
60gの無水酪酸を使用して行つた。
63g(収率95%)の生成物が得られ、その分析
値は理論値とよく一致した。
窒素含有量:実測値、8.2%(理論値:7.3%)。
酸指数:実測値;260(理論値:253)。
本発明の化粧料組成物は0.1〜5重量%の活性
成分(α−アミノ酸の酪酸によるN−アシル化
物)と適当な担体とからなる;活性成分をより高
い含有量で使用することは通常、必要ないであろ
う。
本発明の化粧料組成物の例を以下の実施例に示
す。
実施例 1
皮膚保護用クリーム
a ブチリルヒドロキシプロリン(50%) 3
ステアリン 5
ポリオキシエチレン セチル(cetylic)アル
コール 5
パルミチン酸イソプロピル 10
グリセロール 10
防腐剤及び全体が100となる量の水
b ブチリル プロリン 1
aの担体 99
c ブチリル シスチン 1
aの担体 99
d ブチリルヒドロキシプロリン(50%) 2
ポリオキシエチレングリコールステアレート 5
防腐剤及び全体が100となる量の水
e ブチリルグリシン 2
aの担体 98
f ブチリルコラーゲン酸 2
aの担体 98
g ブチリルカゼイン酸 1
ブチリルケラチン酸 1
aの担体 98
h ブチリルコラーゲン酸アルミニウム 2
aの担体 98
注:このクリームは発汗防止において活性を示
す。
実施例 2
毛髪保護用ローシヨン
a ブチリルシステイン 1
エタノール 15
水 全体が100となる量
b ブチリルメチオニン 1
水 全体が100となる量
c ブチリルシスチン 0.5
ブチリルメチオニン 0.5
プロピレングリコール 5
水 全体が100となる量
注:これらのローシヨンは動物にも施し得る。
実施例 3
爪保護用ローシヨン
a ブチリルシスチン 1
水 全体が100となる量
b ブチリルメチオニン 1
エタノール 15
水 全体が100となる量
比較試験
本発明の化粧料組成物において活性成分として
使用するα−アミノ酸の酪酸によるN−アシル化
物は、前記した通り、より長鎖の脂肪族カルボン
酸を用いて得られるN−アシル化物と比較して、
より大きな酸性化能力(すなわち、潜在的な酸性
度)を有しており、従つて本発明で使用するN−
アシル化物を身体の局部に施した場合、皮膚及び
尿のPHを低下させる性質を有する。この性質は本
発明で使用するN−アシル化物が皮膚の状態を改
善しかつ皮膚からの浸透性が良好であることを示
すものであり、かつ、この性質は上記N−アシル
化物を化粧料の活性成分として使用した場合に有
用な性質である。
本発明で使用するα−アミノ酸の酪酸によるN
−アシル化物が上記したごとく、皮膚及び尿のPH
を低下させる性質を有しかつ皮膚からの浸透性が
良好であることを具体的に示すために、下記のご
とき試験を行つた。
女子24人及び男子12人(年令22〜67才)からな
る被検体を、各々、女子4人、男子2人からなる
6個の群に分けた。
これらの群の全てについて、左腕の皮膚のPH
(当所のPH)を測定した。同時に、各被検体から
尿を採取した。
ついで、6人の被検体からなる群の各々を下記
のごとく異なる製剤で処理した。この処理はPHを
測定した左腕の皮膚に製剤を塗布することにより
行つた。
The present invention provides N-amino acids or mixtures thereof.
The present invention relates to a novel cosmetic composition containing at least one acylated product as an active ingredient. It is known to acylate amino acids or mixtures thereof with fatty acids containing more than 5 carbon atoms in the molecular chain. However, although these known acylated products are fat-soluble, they are generally insoluble in water and common solvents. The inventors have now discovered that acylation of α-amino acids or mixtures thereof with butyric acid yields acylated products that are fat-soluble and also soluble in water and many polar and non-polar solvents. . In particular, acylation of amino acids or mixtures thereof with butyric acid yields products soluble in alcohols, ketones, ethyl acetate, benzene, chloroform, diethyl ether, and the like. Of course, solubility in fat, water and various solvents will vary depending on the type of amino acid. These acylates are also soluble in a mixture of polar and non-polar solvents such as methanol and chloroform, but are insoluble in petroleum ether, hexane,
Further, some of the above acylated products are insoluble in isopropyl ether. Compared to lipoamino acids obtained by acylating amino acids or mixtures thereof with fatty acids containing more than 5 carbon atoms in the molecule, acylation with butyric acid results in a shorter molecular chain of the acyl group. , compounds with a greater acidifying capacity (this is the acidity of the free carboxyl group) are obtained. This N-acylated product exhibits good permeability through the skin, and also exhibits useful effects as an active ingredient in cosmetics. Therefore, according to the present invention, a method for protecting skin, hair and nails, which contains as an active ingredient at least one N-acylated α-amino acid obtained by acylating an α-amino acid with butyric acid. A cosmetic composition is provided. In the present invention, salts of the above acylated products with inorganic, organic or biological bases or metals can be used as well. According to the invention, the α-amino acids can be replaced by mixtures of amino acids obtained by any suitable method, for example by complete hydrolysis of proteins. Any product obtained by acylating an amino acid or a mixture of amino acids with butyric acid is an N-acylated derivative; however, in amino acids with other basic functional groups, these functional groups are also partially oxidized by butyric acid. Alternatively, it can be completely acylated. Regarding the salts of the N-acylates of these amino acids or mixtures thereof, the salts may be prepared using any suitable inorganic or organic base such as triethanolamine, diethylamine and morpholine or various known salts such as lysine, arginine or nithine. can be obtained by the action of basic amino acids, or biological bases such as choline and guanidine. The corresponding salts are obtained simply by reacting the previously obtained N-acylated product with the selected base. Regarding the production of metal salts of the N-acylates of the present invention, such metal salts can be easily produced by reacting the N-acylates with the hydroxide or carbonate of the selected metal under heating; Preferred metals are those known as oligo-elements. When producing the N-acylated product of α-amino acid with butyric acid used in the present invention, it is preferable to use butyric anhydride, which generates free butyric acid and completely reacts with the amino acid; ~twenty five%
Although it is preferred to use excess, if the amino acids being treated have other functional groups that can be acylated, these should be considered when determining the appropriate proportion of butyric anhydride to use. It will be necessary to take into account all of the functional groups. An example of the production of an N-acylated product of α-amino acid with butyric acid used in the present invention will be shown below. Production Example 1 Production of butyrylglycine A stirrer was attached and heated in a water bath.
30 g (0.4 mol) of glycine was poured into a 500 ml reaction vessel, and 40 ml of 30% sodium hydroxide solution was slowly added with stirring. When the reaction mixture became clear, 65 g of butyric anhydride were slowly added, maintaining the pH at 10-10.5 (temperature 40-45 DEG C.) until the end of the addition.
The reaction mixture was heated at 70° C. for 0.5 h and then cooled. To obtain butyrylglycine from its sodium salt, hydrochloric acid was slowly added with stirring until the pH reached 2. The oily supernatant layer thus formed was separated and distilled under reduced pressure (on an oil bath) to remove water and hydrochloric acid. After cooling, petroleum ether was added to precipitate butyrylglycine and remove butyric acid; this treatment was repeated twice. Thus, 51 g (88% yield) of product was obtained,
The analytical value is the theoretical value (molecular weight 145; C 6 H 11 NO 3 )
Acid index: measured value, 382 (theoretical value: 386). Production Example 2 Production of butyrylphenylalanine The same method as Production Example 1 was carried out using 33 g (0.2 mol) of phenylalanine and 36 g of butyric anhydride. 42 g (90% yield) of product was obtained, the analysis of which was in complete agreement with the theoretical value (molecular weight 235; C 13 H 17 NO 3 ): acid index; observed value, 235 (theoretical value: 238). . Production Example 3 Production of butyrylthreonine The same method as in Production Example 1 was carried out using 36 g (0.3 mol) of threonine and 51 g of butyric anhydride. 57 g (99% yield) of product were obtained, the analysis of which was in complete agreement with the theoretical value (molecular weight 189; C8H15NO4 ) : acid index; found value, 293 (theoretical value: 296). . Production Example 4 Production of butyryl aspartic acid The same method as Production Example 1 was carried out using 53 g (0.4 mol) of aspartic acid and 64 g of butyric anhydride; however, after the water and hydrochloric acid removal step, the remaining It was necessary to remove the butyric acid by distillation under reduced pressure at 130-140°C (on an oil bath). The anhydrous residue was treated with an equal weight of distilled water and then with carbon black.
75 g (94% yield) of product were obtained, the analysis of which was in perfect agreement with the theoretical value (molecular weight 203 ; C8H13NO5 ): acid index; found, 382 (theoretical value 386). Production Example 5 Production of butyrylvaline The same method as Production Example 1 was carried out using 58 g (0.5 mol) of valine and 85 g of butyric anhydride. Butyrylvaline is only slightly soluble in cold water, so
Butyric acid was removed by washing with ice water. 85 g (92% yield) of product were obtained, the analysis of which was in perfect agreement with the theoretical value (molecular weight 187 ; C9H17NO3 ): acid index; found, 294 (theoretical value 297). Production Example 6 Production of Butyryl Leucine A method similar to Production Example 1 was carried out using 65 g (0.5 mol) of leucine and 85 g of butyric anhydride; since butyryl leucine is only slightly soluble in cold water, Removal was performed in the same manner as in Production Example 5. 89 g (92% yield) of product were obtained, the analysis of which was in perfect agreement with the theoretical value (molecular weight 201 ; C10H19NO3 ): acid index; found, 277 (theoretical value 280). Production Example 7 Production of dibutyryl risine Using 60 g of a 50% solution of lysine (0.2 mol) and 64 g of butyric anhydride for the dibutyryl derivative,
The same method as in Production Example 1 was carried out. 51 g (yield 85%) of product were obtained, the analysis of which was in perfect agreement with the theoretical value (molecular weight 286 ; C14H26N2O2 ) : acid index; observed value, 193 (theoretical value : 195). Production Example 8 Production of butyrylproline The same method as Production Example 1 was carried out using 23 g (0.2 mol) of proline and 40 g of butyric anhydride. 34 g (92% yield) of product was obtained, the analysis of which was in complete agreement with the theoretical value (molecular weight 185 ; C9H15NO3 ): acid index; found value, 304 (theoretical value: 302). . Preparation Example 9 Preparation of mono- and dibutyryl hydroxyproline 52 g (0.4 mol) of hydroxyproline and 75 g
The same method as in Production Example 1 was carried out using butyric anhydride. 75 g (yield: 87%) of product was obtained, and analysis showed that the product was a mixture of mono-substituted (35%) and di-substituted (65%) products. Theoretical values for these compounds are as follows: Monosubstituted: molecular weight 201; C 9 H 15 NO 4 ; acid index
279, di-substituted type; molecular weight 271; C 13 H 21 NO 4 ; acid index 207; actual value for acid index was 230. Production Example 10 Production of dibutyrylhydroxylysine The same method as in Production Example 1 was carried out using 32 g (0.2 mol) of hydroxylysine and 40 g of butyric anhydride. 53 g (yield 88%) of product was obtained, the analysis of which was in complete agreement with the theoretical value (molecular weight 302 ; C14H26N2O5 ): acid index; observed value, 187 (theoretical value: 184). Production Example 11 Production of butyrylmethionine The same method as in Production Example 1 was carried out using 45 g (0.3 mol) of methionine and 50 g of butyric anhydride. 61 g (92% yield) of product were obtained, the analysis of which was in perfect agreement with the theoretical value (molecular weight 219 ; C9H17NO3S ): acid index; found, 257 ( theoretical : 255). ). Production Example 12 Production of dibutyrylcystine The same method as Production Example 1 was carried out using 48 g (0.2 mol) of cystine and 64 g of butyric anhydride. 73 g (91% yield) of product was obtained, the analytical value of which was in perfect agreement with the theoretical value (molecular weight 380; C 14 H 24 N 2 O 6 S 2 ): acid index; observed value, 305 (theoretical). value:
294). Production Example 13 Production of butyrylcysteine The same method as Production Example 1 was carried out using 48 g (0.4 mol) of cysteine and 64 g of butyric anhydride. 71 g (97% yield) of product were obtained, the analysis of which was in perfect agreement with the theoretical value (molecular weight 191 ; C7H13NO3S ): acid index; found, 307 ( theoretical : 297). ).
SH: Actual value, 16.8 (theoretical value: 17.1). The preparation example shown below concerns the preparation of an acylated product with butyric acid of an unseparated amino acid mixture obtained by complete hydrolysis of a natural protein. Since these amino acid mixtures substantially contain the amino acids present in the raw protein in quantitative and qualitative proportions, the above amino acid mixtures are designated by the same name as the raw protein. The first step consists of preparing a protein hydrolyzate from the selected protein. After treating 200 g of protein with concentrated hydrochloric acid according to conventional methods and confirming the absence of peptides by the Biuret test, the solution was neutralized (PH 6.5-7), treated with carbon black and filtered. . The solution thus obtained was titrated with formaldehyde to determine the amine functionality available for acylation and the amount of butyric anhydride to be used. A dry extract was prepared using a sample of the hydrolyzate, weighed, treated with methanol to remove sodium chloride and titrated again with formaldehyde. This preliminary operation allows acylation with appropriate proportions of reactants. Production Example 14 Production of butyryl collagen acid Gelatin was used as the raw protein. The average molecular weight of amino acids in the hydrolyzate was 110. about
200 ml of hydrolyzate containing 50 g of amino acids were treated with 80 g of butyric anhydride according to the method described in Preparation Example 1. The acylated product was separated by distillation in the same manner as in Production Example 4, and 74 g (yield: 92%) was obtained. The analytical values were in good agreement with the theoretical values. Nitrogen content: Actual value, 8.2% (theoretical value: 8%) Acid index: Actual value, 335 (theoretical value: 327) Production Example 15 Production of butyryl keratinic acid Horn was used as the raw protein. The average molecular weight of amino acids in the hydrolyzate was 120.
The amount of acylatable amino functionality was determined for cystine. The production of the acylated product was carried out using 300 ml of hydrolyzate and 80 g of butyric anhydride according to the same method as in Production Example 14; in order to improve the solubility of the acylated products of valine, leucine and isoleucine. 3-5% propylene glycol was added. 87 g (96% yield) of product was obtained, the analytical value of which was in acceptable agreement with the theoretical value. Nitrogen content: Actual value, 8.2% (theoretical value: 7.4
%); this difference is due to the presence of dibasic compounds in the amino acid mixture. Acid index: actual value, 287; theoretical value for butyrylcystine is 294. Production Example 16 Production of butyl casein acid Casein was used as the raw protein. The average molecular weight of amino acids in the hydrolyzate was 120. The acylated product was produced using 300 ml of a hydrolyzate containing about 41 g of amino acid according to the same method as in Production Example 14.
It was carried out using 60 g of butyric anhydride. 63 g (95% yield) of product was obtained, the analytical value of which was in good agreement with the theoretical value. Nitrogen content: actual value, 8.2% (theoretical value: 7.3%). Acid index: Actual value; 260 (theoretical value: 253). The cosmetic composition of the invention consists of 0.1 to 5% by weight of active ingredient (N-acylated α-amino acid with butyric acid) and a suitable carrier; higher contents of the active ingredient are usually used. It probably won't be necessary. Examples of the cosmetic composition of the present invention are shown in the following examples. Example 1 Skin protection cream a Butyryl hydroxyproline (50%) 3 Stearin 5 Polyoxyethylene Cetylic alcohol 5 Isopropyl palmitate 10 Glycerol 10 Preservative and water to make up 100 b Butyryl proline 1 a 99 c Butyryl cystine 1 Carrier for a 99 d Butyryl hydroxyproline (50%) 2 Polyoxyethylene glycol stearate 5 Preservative and water to make a total of 100 e Butyrylglycine 2 Carrier for a 98 f Butyryl cystine Carrier for lylcollagenate 2a 98 g Butyrylcaseinate 1 Butyrylkeratic acid 1a carrier 98 h Aluminum butyrylcollagenate 2a carrier 98 Note: This cream shows activity in antiperspirant. Example 2 Hair protection lotion a Butyrylcysteine 1 Ethanol 15 Water Amount that makes the whole 100 b Butyrylmethionine 1 Water Amount that makes the whole 100 c Butyrylcystine 0.5 Butyrylmethionine 0.5 Propylene glycol 5 Water The whole amount makes 100 NOTE: These lotions may also be administered to animals. Example 3 Nail protection lotion a Butyrylcystine 1 Water Amount b that makes the total 100 Butyrylmethionine 1 Ethanol 15 Water Amount comparison test that makes the whole 100 α- As mentioned above, the N-acylation of amino acids with butyric acid is as follows:
It has a greater acidifying capacity (i.e. acidity potential) and therefore the N-
When acylated products are applied locally to the body, they have the property of lowering the pH of the skin and urine. This property indicates that the N-acylated product used in the present invention improves the skin condition and has good permeability through the skin. This is a useful property when used as an active ingredient. N by butyric acid of α-amino acid used in the present invention
-As mentioned above, acylated products can affect the pH of the skin and urine.
In order to specifically demonstrate that it has the property of lowering the skin temperature and has good permeability through the skin, the following tests were conducted. The subjects, consisting of 24 females and 12 males (age 22-67 years), were divided into 6 groups, each consisting of 4 females and 2 males. For all of these groups, the PH of the skin of the left arm
(PH of our office) was measured. At the same time, urine was collected from each subject. Each group of six subjects was then treated with a different formulation as described below. This treatment was performed by applying the preparation to the skin of the left arm where the PH was measured.
【表】
ついで各被検体から6時間までの間、尿を採取
した;6時間後、各被検体の前記皮膚のPHを測定
し、また、採取した尿全体のPHも測定した。これ
らのPHの測定値を後記の第1表に示す。なお、上
記製剤の調製に使用したベースエマルジヨンの組
成は下記の通りである:
ポリエチレングリコールステアレート 10
ステアリン酸 5
グリセリン 3
ポリオキシエチレン化セチルアルコール 2
水 80
100部
ベースエマルジヨンのPH=6.1
上記試験を行う際、前記製剤で処理する前及び
処理の6時間後に、製剤を施した部分の皮膚の水
和指数(hydration index)も測定した。皮膚の
水和(保水)性は、皮膚の健康状態の良否の尺度
として利用し得る。
水和の程度は皮膚の抵抗値を測定し、測定値に
基づいて下記の等級で表わした。等 級
水和の程度
11〜12 水和が極めて不充分
13〜16 水和がやゝ不充分
17〜19 標準的な水和状態
20 水和過度
水和指数の測定結果も第1表に示した。
第1表に示すデーターから、本発明のN−アシ
ル化物は、より短鎖の脂肪酸又はより長鎖の脂肪
酸によるアシル化物と比較して、皮膚のPHを低下
させる能力がより大きく、皮膚からの浸透性も大
きくそして皮膚の水和性を改善する性質も良好で
あることが認められる。[Table] Urine was then collected from each subject for up to 6 hours; after 6 hours, the PH of the skin of each subject was measured, and the PH of the entire collected urine was also measured. These measured PH values are shown in Table 1 below. The composition of the base emulsion used to prepare the above formulation is as follows: Polyethylene glycol stearate 10 Stearic acid 5 Glycerin 3 Polyoxyethylated cetyl alcohol 2 Water 80 100 parts PH of base emulsion = 6.1 Above During the test, the hydration index of the skin in the area treated with the formulation was also measured before and 6 hours after treatment with the formulation. Skin hydration (water retention) can be used as a measure of skin health. The degree of hydration was determined by measuring the resistance value of the skin, and expressed in the following grade based on the measured value. Grade degree of hydration 11-12 Extremely insufficient hydration 13-16 Slightly insufficient hydration 17-19 Standard hydration state 20 Excessive hydration The measurement results of the hydration index are also shown in Table 1. Ta. From the data shown in Table 1, the N-acylated product of the present invention has a greater ability to lower skin PH than acylated products with shorter chain fatty acids or longer chain fatty acids, and has a greater ability to reduce skin PH. It is recognized that the permeability is high and the property of improving skin hydration is also good.
【表】【table】
Claims (1)
れるα−アミノ酸のN−アシル化物の少なくとも
1種を活性成分として含有することを特徴とす
る、皮膚、毛髪及び爪保護用化粧料組成物。 2 活性成分が、蛋白質の完全加水分解により得
られるアミノ酸の混合物の酪酸によるアシル化物
である、特許請求の範囲第1項記載の組成物。 3 活性成分を約0.1〜5%含有する、特許請求
の範囲第1項または第2項に記載の組成物。[Scope of Claims] 1. A cosmetic for protecting skin, hair, and nails, which contains as an active ingredient at least one N-acylated product of α-amino acid obtained by acylating α-amino acid with butyric acid. composition. 2. The composition according to claim 1, wherein the active ingredient is an acylated product of a mixture of amino acids obtained by complete hydrolysis of proteins with butyric acid. 3. A composition according to claim 1 or 2, containing about 0.1 to 5% active ingredient.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8106592A FR2503151A1 (en) | 1981-04-02 | 1981-04-02 | Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57183703A JPS57183703A (en) | 1982-11-12 |
| JPH0242805B2 true JPH0242805B2 (en) | 1990-09-26 |
Family
ID=9256906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5399982A Granted JPS57183703A (en) | 1981-04-02 | 1982-04-02 | Novel composition for cosmetics, sanitation, treatment or agricultural gardening |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS57183703A (en) |
| FR (1) | FR2503151A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3727897A1 (en) * | 1987-08-21 | 1989-03-02 | Degussa | METHOD FOR PRODUCING N-ACYLATED MERCAPTO (ALPHA) AMINO ACIDS |
| FR2619711B1 (en) * | 1987-09-02 | 1991-01-11 | Givaudan La Virotte Cie Ets | COSMETIC APPLICATION OF PROLINE DERIVATIVES, HYDROXYPROLINE AND / OR MIXTURE OF AMINO ACIDS RESULTING FROM COLLAGEN HYDROLYSIS |
| SE8901570D0 (en) * | 1989-05-02 | 1989-05-02 | Draco Ab | ORGANIC SALTS OF CYSTEINE DERIVATIVES |
| GB8918708D0 (en) * | 1989-08-16 | 1989-09-27 | Unilever Plc | Cosmetic composition |
| GB8918709D0 (en) * | 1989-08-16 | 1989-09-27 | Unilever Plc | Cosmetic composition |
| IL97012A0 (en) * | 1990-01-30 | 1992-03-29 | Gist Brocades Nv | Topical preparations for treating human nails |
| IL98310A (en) * | 1990-06-08 | 1996-08-04 | Astra Ab | Pharmaceutical compositions comprising cystine derivatives |
| SE9002067D0 (en) | 1990-06-08 | 1990-06-08 | Astra Ab | THE PHARMACOLOGICAL USE OF CERTAIN CYSTINE DERIVATIVES |
| TW221376B (en) * | 1990-06-28 | 1994-03-01 | Astra Ab | |
| US5889050A (en) * | 1991-06-21 | 1999-03-30 | Astra Aktiebolag | 3,3'-dithiobis (propionic acids) and esters thereof |
| TW222591B (en) * | 1991-08-30 | 1994-04-21 | Procter & Gamble | |
| SE9103572D0 (en) * | 1991-11-29 | 1991-11-29 | Astra Ab | ORGANIC SALTS OF N, N'-DIACETYL CYSTINE |
| FR2731220B1 (en) * | 1995-03-03 | 1997-05-23 | Bieurope | DISUCCINYL-L-CYSTINE SALTS, THEIR PREPARATION, AND THEIR USE IN COSMETICS |
| SE9500897D0 (en) * | 1995-03-14 | 1995-03-14 | Astra Ab | The pharmacological use of certain cysteine derivatives |
| JP2002080321A (en) * | 2000-06-20 | 2002-03-19 | Kyowa Hakko Kogyo Co Ltd | Cosmetics |
| JP4841075B2 (en) * | 2000-09-22 | 2011-12-21 | 旭化成ケミカルズ株式会社 | Whitening cosmetics |
| JP6162579B2 (en) * | 2013-11-14 | 2017-07-12 | 雪印メグミルク株式会社 | New bacteriostatic or antibacterial agent |
| FR3050108B1 (en) * | 2016-04-13 | 2019-07-05 | Societe La Biochimie Appliquee | COSMETIC AND / OR DERMATOLOGICAL COMPOSITION FOR THE COMPACTION OF STRATUM CORNEUM |
| CN108029863B (en) * | 2018-01-19 | 2021-07-27 | 广州英赛特生物技术有限公司 | Application of butyrylglycine and derivative thereof in preparation of animal feed additive |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2470M (en) * | 1962-03-13 | 1964-04-20 | Mead Johnson & Co | Therapeutic composition. |
| FR1462498A (en) * | 1965-11-10 | 1966-04-15 | New sulfur-containing substances for human skin care | |
| US3950542A (en) * | 1967-02-21 | 1976-04-13 | L'oreal | Cysteamine derivatives for oral treatment of seborrhea |
| FR8205M (en) * | 1968-12-20 | 1970-09-14 | ||
| BE790592A (en) * | 1971-10-28 | 1973-04-26 | Oreal | |
| JPS53149926A (en) * | 1977-05-18 | 1978-12-27 | Kowa Co | Methylmethionine sulfonium derivative |
-
1981
- 1981-04-02 FR FR8106592A patent/FR2503151A1/en active Granted
-
1982
- 1982-04-02 JP JP5399982A patent/JPS57183703A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2503151A1 (en) | 1982-10-08 |
| JPS57183703A (en) | 1982-11-12 |
| FR2503151B1 (en) | 1984-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0242805B2 (en) | ||
| US4859653A (en) | Use of compositions of matter containing N-acylates of alpha aminoacids for the treatment of skin | |
| JP2705848B2 (en) | N-acylated derivatives of mixtures of amino acids derived from hydrolyzates of cereal proteins and their applications | |
| US20020042438A1 (en) | Use of ergothioneine and/or its derivatives as an anti-glycation agent | |
| JP4358996B2 (en) | External preparation composition | |
| CH527218A (en) | Process for making alcohol-soluble aluminium complexes of formula (I): Al2(H2O)y-pz (OH)6-nxCln(R)p where R=is the coordinating moiety of a poly-hyd | |
| JPH11506130A (en) | Sunshine-free tanning compositions and methods | |
| JP2886591B2 (en) | Cosmetics | |
| JPS6165866A (en) | Pyroglutamic acid ester, synthesis and use for local product | |
| Nimni | Mechanism of inhibition of collagen crosslinking by penicillamine | |
| EP3504218B1 (en) | Composition comprising silicon and method for preparing same | |
| JPH0330566B2 (en) | ||
| DE69119246T2 (en) | Solvents and solubilizers for silicones | |
| JP2983517B2 (en) | Novel salicylic acid derivatives and their use in cosmetic and / or dermatological compositions | |
| KR920004093B1 (en) | Cosmetic composition | |
| JPS632534B2 (en) | ||
| DE69424690T2 (en) | METHOD FOR PRODUCING COLLAGEN FROM CNIDARIANS AND CORRESPONDING COSMETIC COMPOSITIONS | |
| JPH03135949A (en) | Novel urethane derivative, method for producing the same, and cosmetic or pharmaceutical composition containing the same | |
| JP3623548B2 (en) | Cosmetics | |
| FR2503144A1 (en) | Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use | |
| JPH02267A (en) | Sulfonamide derivative and cosmetic composition | |
| CA1134824A (en) | Cosmetic composition for the treatment of seborrhea, novel composition and preparation process | |
| JPH0157083B2 (en) | ||
| IE50900B1 (en) | Composition for the hydration of keratinic substances | |
| JP2781982B2 (en) | External preparation for skin |